05 June 2023
  • At  the beginning of Pride Month, Novartis in Slovenia has raised a rainbow flag at its locations in support of the LGBTQI+ community.
  • By donning the rainbow flag, the company is raising awareness of basic human rights and advocating for an end to discrimination based on sex, gender, sexual orientation and other personal circumstances.
  • The company recognizes diversity, inclusion and equity as core values and the foundation for innovation and progress.

Ljubljana, June 5, 2023 – Novartis in Slovenia raised the rainbow flag in Ljubljana and Mengeš in support of Pride Month. This symbolic act demonstrates the company's support for its associates and other members of the LGBTQI+ community, as well as its commitment to respecting their rights and ensuring their equal social inclusion.

Creating an inclusive work environment and promoting diversity in the workplace is at the core of our company's culture: "Diversity and inclusion are two of our core values. When we feel included and accepted, we can best contribute to our collective success and progress, which is why we prioritize mutual respect and equity as an integral part of our culture," stated Aymeric Royere, NovartisCountry President Slovenia and General Manager Innovative Medicines Slovenia.For many years, the company has implemented a number of measures to ensure an inclusive and equal working environment. "Every day, we strive to ensure that our associates – regardless of their personal circumstances or limitations– are valued for their abilities and contribution to our common mission,"added Jana Petek, CEO, Novartis d.o.o

The company has been flying the rainbow flag in support of Pride Month for several years, setting an important example for the general public. The main focus of activities in the area of LGBTQI+ inclusion is raising awareness about the legal and social status of the community, fight for equal rights, abolition of discrimination and acceptance of diversity. During PrideMonth, a rainbow flag is proudly displayed in front of our office buildings asa show of support.

* * *

About Novartis

Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 103,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. Find out more at https://www.novartis.com

* * *

This press release contains statements and forecasts of future business operations. The forecasts include estimates based on all the information currently available to us. Should these forecasts prove unreliable, the actual results of business operations could be different from those expected.

- end -

For further information, please contact:

Mateja Breznik

Communication & Engagement 

Novartis LLC

 [email protected]